Sign in

Anna Jeanne Lizzul

Vice President and Equity Research Analyst at Bank of America

Anna Jeanne Lizzul is a Vice President and Equity Research Analyst at Bank of America, specializing in coverage of beauty, personal care, and household products with a track record of notable stock calls such as Coty, Elf Beauty, Kenvue, Clorox, and Kimberly-Clark. Her success rate on TipRanks stands at 55.2%, with her bullish recommendations on Coty and Elf Beauty contributing to strong sector outperformance and recognition as one of Business Insider's rising stars of equity research in 2023. Lizzul began her Wall Street career after analyst roles at JPMorgan Chase and Wells Fargo, joining Bank of America in 2022 and quickly becoming a key voice in consumer products research. She holds FINRA registrations and maintains relevant securities licenses with no reported violations.

Anna Jeanne Lizzul's questions to CLOROX CO /DE/ (CLX) leadership

Question · Q1 2026

Anna Jeanne Lizzul asked about potential retailer destocking trends and Clorox's exposure, especially given the ERP transition. She also inquired about increasing exposure to club and online channels, particularly for Glad, and any innovation tailored for these retailers or new pack sizes. Additionally, she sought thoughts on private label share growth, specifically in categories like wipes.

Answer

CEO Linda Rendle confirmed that the ERP implementation led to inventory rebuilding, so Clorox is not experiencing material destocking, and inventories are largely recovered. She noted a strong club business with specific innovation for members, acknowledging Glad has less club presence but strong distribution elsewhere for large sizes. On private label, she stated no material aggregate inroads, but highlighted Brita filters and bleach as categories being carefully watched for private label uptick, while the cleaning portfolio generally performs well against private label.

Ask follow-up questions

Get Instant Answers from SEC Filings & Earnings Calls

Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.

Search across 8,000+ companies
Access millions of SEC filings & transcripts
Get answers cited to the source
Try Fintool for Free

Trusted by leading investment firms and analysts